Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 1
2020 4
2021 4
2022 7
2023 10
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice.
Suárez-García I, Alejos B, Hernando V, Viñuela L, Vera García M, Rial-Crestelo D, Pérez Elías MJ, Albendín Iglesias H, Peraire J, Tiraboschi J, Díaz A, Moreno S, Jarrín I; Cohort of the Spanish HIV/AIDS Research Network (CoRIS). Suárez-García I, et al. Among authors: rial crestelo d. J Antimicrob Chemother. 2023 Jun 1;78(6):1423-1432. doi: 10.1093/jac/dkad102. J Antimicrob Chemother. 2023. PMID: 37099559 Free PMC article.
Cabotegravir and rilpivirine for the treatment of HIV.
Rial-Crestelo D, Pinto-Martínez A, Pulido F. Rial-Crestelo D, et al. Expert Rev Anti Infect Ther. 2020 May;18(5):393-404. doi: 10.1080/14787210.2020.1736561. Epub 2020 Mar 12. Expert Rev Anti Infect Ther. 2020. PMID: 32164474
Deep Sequencing on Proviral DNA: More Questions than Answers.
Rial-Crestelo D, Pinto-Martínez A, Navarro-Soler R, Pulido F. Rial-Crestelo D, et al. J Acquir Immune Defic Syndr. 2023 Sep 1;94(1):e1. doi: 10.1097/QAI.0000000000003230. J Acquir Immune Defic Syndr. 2023. PMID: 37256638 No abstract available.
Virologic Response to Dolutegravir Plus Lamivudine in People With Suppressed Human Immunodeficiency Virus Type 1 and Historical M184V/I: A Systematic Literature Review and Meta-analysis.
Kabra M, Barber TJ, Allavena C, Marcelin AG, Di Giambenedetto S, Pasquau J, Gianotti N, Llibre JM, Rial-Crestelo D, De Miguel-Buckley R, Blick G, Turner M, Harrison C, Wynne T, Verdier G, Parry CM, Jones B, Okoli C, Donovan C, Priest J, Letang E. Kabra M, et al. Among authors: rial crestelo d. Open Forum Infect Dis. 2023 Oct 27;10(11):ofad526. doi: 10.1093/ofid/ofad526. eCollection 2023 Nov. Open Forum Infect Dis. 2023. PMID: 38033982 Free PMC article.
Use of Tenofovir Alafenamide/Emtricitabine/Elvitegravir-Cobicistat in HIV-Naive Patients with Advanced Disease: GENIS Study.
Perez Stachowski J, Rial Crestelo D, Moreno Zamora A, Cabello N, Ryan P, Espinosa Aguilera N, Bisbal O, Vivancos Gallego MJ, Nuñez MJ, Troya J, Dominguez M, Sierra JO. Perez Stachowski J, et al. Among authors: rial crestelo d. J Clin Med. 2022 Aug 25;11(17):4994. doi: 10.3390/jcm11174994. J Clin Med. 2022. PMID: 36078925 Free PMC article.
24 results